Healthcare Services

Genome Editing/Genome Engineering Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Genome Editing/Genome Engineering Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The market size for genome editing/genome engineering has seen rapid expansion in recent years. It is anticipated to grow from $10.17 billion in 2025 to $12.15 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.5%. Historically, this growth can be attributed to the discovery of genome editing techniques, early research applications, the availability of molecular biology tools, an increase in academic research funding, and the demand for disease modeling.

The genome editing/genome engineering market is set to experience substantial expansion over the next few years. Its valuation is projected to reach $24.53 billion by 2030, advancing at a compound annual growth rate (CAGR) of 19.2%. This anticipated increase during the forecast period is primarily driven by the clinical application of gene editing therapies, the growing reach of agricultural genomics, enhanced accuracy in editing techniques, the development of ethical guidelines, and the commercialization of various genome editing services. Significant trends expected in the forecast period include the increasing uptake of CRISPR-based editing instruments, the broadening use of genome editing in disease research, a surge in cell line engineering applications, an escalating need for precise gene modification, and amplified research funding from academic and government bodies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

What Key Drivers Are Influencing The Growth Of The Genome Editing/Genome Engineering Market?

The genome editing and genome engineering market is projected to grow, driven by an uptick in research activities. These activities encompass structured and methodical endeavors undertaken by researchers, groups, or organizations to collect, evaluate, understand, and produce novel information or understanding within a specific academic area. Crucially, genome editing and genome engineering have emerged as key drivers amidst the escalating volume of research, fundamentally altering the realm of scientific discovery. Such innovative instruments provide scientists with the capability to precisely alter and thoroughly grasp the complex genetic makeup of living beings, presenting unmatched accuracy and adaptability. As an illustration, the National Institute of Neurological Disorders and Stroke, a US-based government research institute, stated in July 2023 that the NIH allocated over $140 million to expedite the transition of genome editing methods from laboratory settings to clinical applications. Consequently, the expanding scope of research activities is propelling the genome editing and genome engineering market.

What Major Segment Divisions Exist Within The Genome Editing/Genome Engineering Market?

The genome editing/genome engineering market covered in this report is segmented –

1) By Product And Service: Reagents And Consumables, Software And Systems, Services

2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies

3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications

4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

Subsegments:

1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents

2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems

3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

How Are Trends Transforming The Genome Editing/Genome Engineering Market Landscape?

Leading firms are forming alliances and entering into partnerships to enhance their position within the genome editing and genome engineering sector. Such strategic business partnerships involve a formalized association between two or more commercial entities, typically established through business agreements or contracts. For instance, in April 2024, Regeneron Pharmaceuticals, a US-based biopharmaceutical company specializing in immunology, oncology, and genetic illnesses, established a collaboration with Mammoth Biosciences, a US-based biotech firm co-founded by Jennifer Doudna, known for its expertise in CRISPR-based gene editing. Through this alliance, Regeneron intends to integrate Mammoth’s unique ultra-small CRISPR platforms with its own delivery technologies to expedite the creation of in vivo gene editing treatments for tissues beyond the liver, thereby broadening Regeneron’s therapeutic offerings and technological capabilities. Mammoth Biosciences, a company based in the United States, offers CRISPR-based genome editing systems, including its proprietary small Cas enzymes, for both therapeutic and diagnostic applications.

Which Companies Are Leading Innovation In The Genome Editing/Genome Engineering Market?

Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

Read the full genome editing/genome engineering market report here:

https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Genome Editing/Genome Engineering Market?

North America was the largest region in the gene editing/genome engineering market in 2025. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Genome Editing/Genome Engineering Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp

Browse Through More Reports Similar to the Global Genome Editing/Genome Engineering Market 2026, By The Business Research Company

Warts Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Genital Herpes Global Market Report

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Vaginal Sling Global Market Report

https://www.thebusinessresearchcompany.com/report/vaginal-sling-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795